Genotyping and clarithromycin susceptibility testing of Mycobacterium avium subsp. hominissuis isolated in Tuscany, Italy

Mycobacterium avium subsp. hominissuis (MAH) is a major cause of nontuberculous mycobacteria infection and the incidence of MAH infections is increasing in many countries. This study aimed at determining the VNTR-based genetic diversity and the susceptibility to clarithromycin of a collection of 71 MAH human strains isolated in the last seven years. The VNTR analysis, revealing 16 unique patterns and 8 clusters including a total of 55 isolates, showed that most MAH isolates displayed a close genetic relationship, indicating that the MAH genotypes are quite homogeneous in our geographical area. Clarithromycin showed strong antimicrobial activity against MAH isolates, as indicated by the high proportion (94.4%) of susceptible strains. No association between specific VNTR patterns and the clinical features or the MIC of clarithromycin was found. •VNTR analysis and clarithromycin susceptibility testing of isolates of Mycobacterium avium subsp. hominissuis were performed.•The Mycobacterium avium subsp. hominissuis genotypes are highly homogeneous.•Clarithromycin showed strong antimicrobial activity against Mycobacterium avium subsp. hominissuis isolates.•No association between specific VNTR patterns and the clinical features or the MIC of clarithromycin was found.